Exicure Inc (XCUR) Stock Analysis

Exicure Inc (XCUR) is a publicly traded company in the HEALTHCARE sector. It trades at $3.11, carries a market capitalization of $21.23M. This page summarizes the public market data, fundamentals, and frequently asked questions for XCUR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.11
• Market Cap: $21.23M
• EPS: $-1.57
• 52-Week High: $10.80
• 52-Week Low: $2.63

Market Sentiment

Exicure Inc currently has a Bearish sentiment score of -0.16.

About Exicure Inc

Exicure, Inc. is a clinical-stage biotechnology company based in Chicago, Illinois, focused on pioneering therapies through its proprietary spherical nucleic acid (SNA) technology. The company's robust pipeline targets a range of serious conditions, encompassing neurological disorders, immuno-oncology, inflammatory diseases, and genetic disorders. By harnessing its innovative SNA technology, Exicure is not only aiming to transform treatment paradigms but also to lead the advancement of RNA-ba...

GNG Research Analysis

GNG Research scores Exicure Inc (XCUR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for XCUR.

Frequently Asked Questions

Does XCUR pay dividends?

Exicure Inc (XCUR) does not currently pay a regular dividend.

What is XCUR's market cap?

Exicure Inc (XCUR) has a market capitalization of $21.23M with a current stock price of $3.11.